Aspergillosis Clinical Trials

3 recruiting

Aspergillosis Trials at a Glance

24 actively recruiting trials for aspergillosis are listed on ClinicalTrialsFinder across 6 cities in 17 countries. The largest study group is Not Applicable with 3 trials, with the heaviest enrollment activity in Jinan, Manchester, and Leuven. Lead sponsors running aspergillosis studies include Qianfoshan Hospital, Post Graduate Institute of Medical Education and Research, Chandigarh, and Bochud Pierre-Yves.

Browse aspergillosis trials by phase

Treatments under study

About Aspergillosis Clinical Trials

Looking for clinical trials for Aspergillosis? There are currently 3 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Aspergillosis trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Aspergillosis clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 24 trials

Recruiting

Natural History of Individuals With Immune System Problems That Lead to Fungal Infections

Invasive AspergillosisAPECEDChronic Mucocutaneous Candidiasis+1 more
National Institute of Allergy and Infectious Diseases (NIAID)1,200 enrolled1 locationNCT01386437
Recruiting

A Cohort Study of the Efficacy and Safety of Biologics in Patients With ABPA

Allergic Bronchopulmonary AspergillosisEfficacy and SafetyABPA+3 more
Qianfoshan Hospital50 enrolled1 locationNCT07362693
Recruiting

Real-World Effectiveness of Benralizumab in Allergic Bronchopulmonary Aspergillosis

Allergic Bronchopulmonary AspergillosisSevere AsthmaABPA
Qianfoshan Hospital20 enrolled2 locationsNCT07530770
Recruiting
Not Applicable

Oral Itraconazole Versus Combination of Systemic Glucorticoids and Oral Itraconazole in CPA-ABPA Overlap Syndrome

Allergic Bronchopulmonary AspergillosisChronic Pulmonary Aspergillosis
Post Graduate Institute of Medical Education and Research, Chandigarh104 enrolled2 locationsNCT05444946
Recruiting

A Study of the Efficacy and Safety of Bronchoscopic Airway Clearance and Amphotericin B Spraying in Patients With ABPA

Airway ClearanceAllergic Bronchopulmonary AspergillosisABPA+1 more
Qianfoshan Hospital44 enrolled1 locationNCT07362667
Recruiting

PCR for Aspergillus Fumigatus in Blood and Bronchoalveolar Lavage Fluid for Monitoring Cases of Invasive Aspergillosis: What is Its Prognostic Value

Invasive Pulmonary Aspergillosis
University Hospital, Strasbourg, France100 enrolled1 locationNCT07313527
Recruiting
Not Applicable

PTX3-targeted Antifungal Prophylaxis

Acute Myeloid LeukemiaGenetic PredispositionCandidiasis+2 more
Bochud Pierre-Yves410 enrolled9 locationsNCT03828773
Recruiting

Influenza Associated Aspergillosis In-depth Investigation

Invasive Pulmonary AspergillosisInfluenza With Pneumonia
Universitaire Ziekenhuizen KU Leuven45 enrolled1 locationNCT03748069
Recruiting
Phase 2

Rezafungin for Treatment of Chronic Pulmonary Aspergillosis (CPA) in Adults With Limited Treatment Options

Chronic Pulmonary Aspergillosis
Mundipharma Research Limited60 enrolled37 locationsNCT06794554
Recruiting

Pathogenesis and Inflammatory Phenotype of Allergic Bronchopulmonary Aspergillosis

Allergic Bronchopulmonary Aspergillosis (ABPA)
Qianfoshan Hospital140 enrolled1 locationNCT07040332
Recruiting

Post Marketing Surveillance (PMS) Study of Cresemba in Korea.

AspergillosisMucormycosis
Pfizer600 enrolled1 locationNCT04744454
Recruiting
Phase 2

iMagIng pulmonaRy Aspergillosis Using Gallium-68-dEferoxamine

Allergic Bronchopulmonary AspergillosisChronic Pulmonary AspergillosisPulmonary Aspergillosis
Radboud University Medical Center10 enrolled1 locationNCT06244979
Recruiting

Breath Analysis for the Detection of Invasive Fungal Infections

LeukemiaLeukemia, MyeloidLeukemia, Lymphoblastic+4 more
University of Zurich130 enrolled1 locationNCT06537726
Recruiting

Impact of Chronic Pulmonary Aspergillosis (CPA) on Health Status and Well-being

Chronic Pulmonary Aspergillosis
Imperial College London100 enrolled3 locationsNCT06885905
Recruiting
Phase 2

Interferon-gamma as Adjunctive Therapy in Chronic Pulmonary Aspergillosis: a Randomised Feasibility Study

AspergillosisChronic Pulmonary Aspergillosis
Manchester University NHS Foundation Trust50 enrolled1 locationNCT05653193
Recruiting
Phase 3

A Randomized Trial of Prednisolone, Itraconazole, or Their Combination in Allergic Bronchopulmonary Aspergillosis

Allergic Bronchopulmonary Aspergillosis
Post Graduate Institute of Medical Education and Research, Chandigarh300 enrolled1 locationNCT06174922
Recruiting
Phase 4

Posaconazole Pharmacokinetics in Patients Receiving Chemotherapy or Stem Cell Transplants

Invasive AspergillosisFungal InfectionPharmacokinetics+4 more
Melbourne Health100 enrolled1 locationNCT03717623
Recruiting
Phase 3

Chronic Pulmonary Aspergillosis and Ambisome Aerosol with Itraconazole

Chronic Pulmonary Aspergillosis
Poitiers University Hospital224 enrolled1 locationNCT03656081
Recruiting
Not Applicable

Study on Theraputic Drug Monitoring and Phamacokinetics of Isavuconazole in Children

MucormycosisAspergillosis Invasive
Shanghai Children's Medical Center200 enrolled1 locationNCT06440915
Recruiting

Non-Invasive Diagnosis of Pediatric Pulmonary Invasive Mold Infections

Pulmonary Invasive Fungal InfectionsPulmonary Invasive Aspergillosis
Arkansas Children's Hospital Research Institute400 enrolled33 locationsNCT03827694